Amador Bioscience completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG)
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
📰 Model Informed Drug Development News
Page 2 - Model Informed Drug Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Model Informed Drug Development. Real-time updates on events, politics, business and more.
Amador Bioscience completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG)
/PRNewswire/ -- Amador Bioscience, a global translational sciences and clinical pharmacology CRO, announced today that it has completed the acquisition of Ann...
Amador Bioscience William Jusko Professor Of Pharmaceutical Sciences Drug Development Distinguished Professor Pharmaceutical Sciences
Source: prnewswire.com
Amador Bioscience completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG)
/PRNewswire/ -- Amador Bioscience, a global translational sciences and clinical pharmacology CRO, announced today that it has completed the acquisition of Ann...
Amador Bioscience William Jusko Professor Of Pharmaceutical Sciences Drug Development Distinguished Professor Pharmaceutical Sciences
Source: prnewswire.com
Japan's Pharmaceuticals and Medical Devices Agency (PMDA)
Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Biosimulation Software for Evaluating Regulatory Submissions The PMDA enters 8th consecutive year of using Certara’s biosimulation software June 23, 2021 19:00 ET | Source: Certara Certara Princeton, New Jersey, UNITED STATES PRINCETON, N.J., June 23, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced that the Japanese Pharma...
United States David Deuchler William Feehery Certara Simcyp Japan Ministry Of Health Japanese Pharmaceuticals
Source: globenewswire.com